Stockreport

Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason [Seeking Alpha]

Nkarta, Inc.  (NKTX) 
PDF NKX019, the lead CAR-NK candidate, shows promising early preclinical results in B cell depletion and is advancing through Ntrust-1 and Ntrust-2 trials. NKTX boasts a [Read more]